The U.K.-based consultancy firm Assero and the European CRO S-Cubed have joined forces to establish A3 Informatics, a joint venture that is designed to help companies working with CDISC (Clinical Data Interchange Standards Consortium) standards and assist with data management. The plan is to showcase the business at the PhUSE Annual Conference in Edinburgh, Scotland on October 8, 2017.
“I am proud to be bringing a set of technologies to the industry that it has long needed,” noted Dave Iberson-Hurst, who has advocated the use of standards for the last 15 years and has helped design and develop A3 Informatics’ “Tools: The Glandon Suite.” “I am looking forward to introducing A3 Informatics to the wider community and changing the way that we work with data.”
Iberson-Hurst has worked with S-Cubed’s managing director Scott McGregor and partner Niels Both for more than a decade. S-cubed is a European company based in Denmark and the U.K. with full-service CRO capabilities, specializing in biometrics, CDISC standards (implementation and conversion), regulatory affairs, business intelligence, quality assurance, and project management.
Both’s experience of working with CDISC standards and awareness of the issues that companies faced with implementation will be vital for A3 Informatics, according to a joint statement from both companies.
“Dave and I have worked together for many years and it is clear that there has to be another way of working with the data in clinical trials,” he said. “A3 Informatics offers solutions that can drive the industry away from endless mapping and conversions and lead to a more efficient and accurate way of working.”
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Tirzepatide Reduces Heart Failure Risk, Improves Physical Function in HFpEF Patients
November 18th 2024The Phase III SUMMIT trial showed that tirzepatide significantly reduces the risk of worsening heart failure events or death from cardiovascular causes, enhances physical function, and leads to weight loss and reduced inflammation in patients with heart failure with preserved ejection fraction.